ETF.com Insight
Akero Therapeutics, Inc. is a company in the U.S. stock market and it is a holding in 50 U.S.-traded ETFs. AKRO has around 4.3M shares in the U.S. ETF market. The largest ETF holder of AKRO is the SPDR S&P Biotech ETF (XBI), with approximately 1.59M shares. Investors may also find of interest that the ETF with the largest allocation to AKRO stock is Invesco DWA Healthcare Momentum ETF (PTH), with a portfolio weight of 2.31%. On average, U.S. ETFs allocate 0.24% of AKRO to their portfolios.
Additionally, AKRO is a favorite stock for Vanilla and Active ETFs. It is also most likely to belong to Broad-based ETFs. The best-performing ETF in the past 12 months with AKRO as a holding is the iShares Biotechnology ETF (IBB), with a return of 0.01%.